FGF23 and chronic kidney disease: Dysregulated mineral metabolism in CKD is closely linked to iron dyshomeostasis and contributes to adverse patient outcomes, including bone diseases and cardiovascular disease, in part through greatly increased FGF23 levels (22, 23).